Texts from your doctor could help prevent diabetes

NCT ID NCT04773834

Completed Prevention Sponsor: NYU Langone Health Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether automated messages from doctors could keep people with prediabetes engaged in a digital diabetes prevention program. Over 550 participants used the Noom app along with a fitness tracker and scale, and some received tailored text or MyChart messages based on their activity. The goal was to see if these nudges could help people lose weight, lower blood sugar, and prevent type 2 diabetes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: automated text and MyChart messages tailored to patient engagement levels
What this could lead to: If it works, this could offer a low-cost way to help people with prediabetes stay engaged in prevention programs and lower their risk of developing diabetes.
What could go wrong: This is a completed study with 551 participants, but the intervention is just messaging—it may not be enough to cause lasting behavior change or improve health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRE-DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glucose intolerance prediabetes syndrome type 2 diabetes mellitus prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRE-DIABETES

Contacts and locations

Locations

NYU Langone Health

New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.